(Q36275397)

English

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS) (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Krista L Lanctôt

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

B Paes

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

I Mitchell

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

CARESS Investigators

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

31

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2703-2711

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

copyright license

Creative Commons Attribution 2.0 Generic

1 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Household tobacco smoke and admission weight predict severe bronchiolitis in infants independent of deprivation: prospective cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Epidemiology and prevention of respiratory syncytial virus infections among infants and young children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Central apnoeas in infants with bronchiolitis admitted to the paediatric intensive care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Inhibition of IFN-gamma-dependent antiviral airway epithelial defense by cigarette smoke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Severe respiratory syncytial virus infection among otherwise healthy prematurely born infants: What are we trying to prevent?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

Does prematurity alter the course of respiratory syncytial virus infection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

30 September 2017

From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

29 June 2018

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

29 June 2018

Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

29 June 2018

Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

29 June 2018

Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

29 June 2018

Validation of a model to predict hospitalization due to RSV of infants born at 33-35 weeks' gestation.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

CARESS: the Canadian registry of palivizumab.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Prospective multicenter bronchiolitis study: predicting intensive care unit admissions

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Risk factors for respiratory syncytial virus associated apnoea

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Cigarette smoke suppresses TLR-7 stimulation in response to virus infection in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1617-7

21 January 2018

Environmental tobacco smoke exposure and respiratory syncytial virus infection in young children hospitalized with acute lower respiratory tract infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

22 September 2018

Bronchiolitis in Abha, Southwest Saudi Arabia: viral etiology and predictors for hospital admission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

22 September 2018

Risk factors for bronchiolitis-associated deaths among infants in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

22 September 2018

Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

22 September 2018

Incidence of respiratory syncytial virus-positive hospitalizations in Germany.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456915

22 September 2018

[Quality of life of preterm infants and admissions due to respiratory infections]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22546928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Recommendations for the prevention of respiratory syncytial virus infection]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22546928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22546928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Recommendations for the use of palivizumab in the prevention of respiratory syncytial virus infection in late preterm infants (32(1) to 35(0) weeks of gestation)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22546928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age

1 reference

https://pubmed.ncbi.nlm.nih.gov/22546928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22546928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The efficiency (cost-effectiveness) of palivizumab as prophylaxis against respiratory syncytial virus infection in premature infants with a gestational age of 32-35 weeks in Spain]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22546928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-012-1617-7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22546928%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36275397&oldid=2198530837"